A Phase 3b, Multicenter, Randomized, Blinded, Active-Controlled Study to Compare the Efficacy and Safety of Ustekinumab to that of Adalimumab in the Treatment of Biologic Naïve Patients with Moderately-to-Severely Active Crohn’s Disease [SEAVUE]

Project: Research

Project Details

Project Description

NMA HREC Reference Number: HREC/44449/MonH-2018-153066
NMA SSA Reference Number: Project ID: 44449
Monash Health Ref: RES-18-0000-568A
StatusActive
Effective start/end date12/12/18 → 11/12/23